Analyst Recommendations

Underperform Recommendation Issued On UTHR By Leerink Partners
Leerink Partners analyst issues UNDERPERFORM recommendation for UTHR on February 22, 2024 09:00AM ET. The previous analyst recommendation was Underperform.UTHR was trading at $219.18 at issue of the...

February 22, 2024   UTHR -0.76%

Buy Recommendation Issued On UFPI By Wedbush
Wedbush analyst issues BUY recommendation for UFPI on February 22, 2024 09:00AM ET. The previous analyst recommendation was Buy.UFPI was trading at $110.11 at issue of the analyst...

February 22, 2024   UFPI -0.49%

Underperform Recommendation Issued On UFPI By Stifel Nicolaus
Stifel Nicolaus analyst issues UNDERPERFORM recommendation for UFPI on February 22, 2024 09:00AM ET. The previous analyst recommendation was Underperform.UFPI was trading at $110.11 at issue of the...

February 22, 2024   UFPI -0.49%

Overweight Recommendation Issued On SRE By Barclays
Barclays analyst issues OVERWEIGHT recommendation for SRE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.SRE was trading at $71.96 at issue of the analyst...

February 22, 2024   SRE 0.84%

Overweight Recommendation Issued On NEE By Barclays
Barclays analyst issues OVERWEIGHT recommendation for NEE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.NEE was trading at $57.1 at issue of the analyst...

February 22, 2024   NEE 0.88%

Sell Recommendation Issued On NEE By Seaport Global
Seaport Global analyst issues SELL recommendation for NEE on February 22, 2024 08:42AM ET. NEE was trading at $57.1 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   NEE 0.88%

Equal-Weight Recommendation Issued On MRNA By Morgan Stanley
Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Equal-Weight.MRNA was trading at $87.59 at issue of the...

February 22, 2024   MRNA 3.42%

Outperform Recommendation Issued On MRNA By Oppenheimer
Oppenheimer analyst issues OUTPERFORM recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Neutral.MRNA was trading at $87.59 at issue of the analyst...

February 22, 2024   MRNA 3.42%

Sector Outperform Recommendation Issued On MOS By Scotiabank
Scotiabank analyst issues SECTOR OUTPERFORM recommendation for MOS on February 22, 2024 04:02AM ET. MOS was trading at $30.23 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   MOS 0.80%

Hold Recommendation Issued On MLM By HSBC
HSBC analyst issues HOLD recommendation for MLM on February 22, 2024 02:48AM ET. MLM was trading at $536.3 at issue of the analyst recommendation.The overall analyst consensus :...

February 22, 2024   MLM 0.29%